Genova Diagnostics acquires Metametrix

Wednesday, July 11, 2012 09:17 AM

Genova Diagnostics, a global specialty clinical laboratory based in Asheville, N.C., has decided to acquire Metametrix, a clinical laboratory in Duluth, Ga.

Genova purchased all assets of Metametrix and will continue to operate under both brands at this time. The combined entity will provide a broader range of testing services, as well as increase the breadth of support and resources dedicated to physicians and their patients.

"We share a mission of improving the health of patients worldwide by striving to be the best provider of comprehensive and innovative clinical laboratory services,” said J. Alexander Bralley, CEO of Metametrix. Bralley will continue working in a consulting capacity in the newly aligned organization, focusing on development of next-generation testing approaches and clinical education programs.

"Consolidating our companies significantly increases our global presence,” said Ted Hull, chairman and CEO of Genova Diagnostics. “Together, we serve over 9,000 healthcare practitioners annually throughout the United States and internationally in 45 countries with our 400 employees and three locations in Asheville, N.C., Duluth, Ga., and London, England. Our combined resources will allow us to expand investments in research & development, clinical trials, medical education and market expansion.”

Financial terms of the transaction were not disclosed.

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs